GlassScriptPhysician profile
Erik Alan Dahl
NPI 1104836311
$2,786.57
in general payments reported to CMS, 2019-2025
9 companies · $2,654 in 2025
The $2,654 reported for 2025 was more than what 83% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.71 · 2021: $17.46 · 2022: $16.41 · 2024: $41.72 · 2025: $2,654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,094 · Food and Beverage: $602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,093.70 |
| Food and Beverage | $602.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,451.47 | 2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Inceptiv |
| Stryker Corporation | $943.22 | 2025 | Mild Device Kit |
| Spr Therapeutics, INC | $202.82 | 2025 | Sprint Pns System |
| Forte Bio-Pharma LLC | $56.76 | 2025 | Prolate, Tanlor, Nalocet |
| Boston Scientific Corporation | $56.71 | 2019 | |
| Abbott Laboratories | $25.58 | 2024 | Eterna |
| Pacira Pharmaceuticals Incorporated | $17.46 | 2021 | |
| Bioventus LLC | $16.41 | 2022 | |
| Avanos Medical | $16.14 | 2024 | Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Dahl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.